All of the following are true regarding Bedaquiline use except: (A) The patient >= 18 years with MDR TB is included, (B) Patient with XDR-TB is eligible for its therapy, (C) Patient should be using hormonal based bih control measure throughout the treatment period, (D) Pregnant patients are excluded
Answer is C. BEDAQUILINEPatient should be using non- hormonal based bih control measure throughout the treatment period The basic criteria for patient selection for bedaquiline is : Age of the patient should be >=18 years having MDR- TB Pregnancy is a contraindication for BDQ therapy and the patient should be using non-hormonal based bih control measure throughout the treatment period or have been postmenopausal for past 2 years; and Cardiac arrhythmia is a contraindication for BDQ treatment -XDR-TB patient is eligible for therapy